About IQVIA Holdings Inc. (IQV)
IQVIA Holdings Inc. is a Diagnostics & Research company operating in the Healthcare sector.
IQV trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $267.33
- Market Cap
- $44.06B
- 52-Week High
- $284.50
- 52-Week Low
- $154.50
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested in IQVIA Holdings Inc. (IQV)
How much would $1,000 invested in IQV be worth today?
What would $1,000 invested in IQV 1 year ago be worth today?
A $1,000 investment in IQVIA Holdings Inc. (IQV) in 2025 would be worth $1,235 as of November 2026, representing a +23.5% total return.
What would $1,000 invested in IQV 3 years ago be worth today?
A $1,000 investment in IQVIA Holdings Inc. (IQV) in 2023 would be worth $1,450 as of November 2026, representing a +45.0% total return.
What would $1,000 invested in IQV 5 years ago be worth today?
A $1,000 investment in IQVIA Holdings Inc. (IQV) in 2021 would be worth $1,039 as of November 2026, representing a +3.9% total return.
What would $1,000 invested in IQV 10 years ago be worth today?
A $1,000 investment in IQVIA Holdings Inc. (IQV) in 2016 would be worth $3,612 as of November 2026, representing a +261.2% total return.
What would $1,000 invested in IQV at IPO be worth today?
A $1,000 investment in IQVIA Holdings Inc. (IQV) at IPO would be worth $6,348 as of November 2026, representing a +534.8% total return.
Monthly Returns Heatmap
Over the past 13+ years (161 months), IQVIA Holdings Inc. (IQV) has averaged a monthly return of +1.47% with a median return of +1.17%. The stock had 89 positive months (55%) and 72 negative months (45%). The best month in IQV's history was April 2020 with a +32.2% return, while the worst was March 2020 at -22.7%. Historically, July tends to be the strongest month (averaging +9.7%), and September the weakest (-3.0%).
IQV's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 4 consecutive months of losses. The best full year was 2021 with a cumulative return of +49.0%, and the worst was 2022 at -26.8%.
Annual Returns
Over 13 years of trading history, IQVIA Holdings Inc. (IQV) has delivered an average annual return of +16.31% with a median return of +16.63%. The compound annual growth rate (CAGR) is +14.43%. The stock posted gains in 11 years (85%) and losses in 2 years (15%).
IQV's best year was 2021 with a +57.47% gain, while the worst was 2022 at -27.38%. The longest streak of consecutive positive years was 8, and the longest losing streak was 1 years. IQV achieved double-digit gains (10%+) in 11 years. It suffered double-digit losses in 2 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +18.60% | $225.41 | $267.33 |
| 2025 | +14.71% | $196.51 | $225.41 |
| 2024 | -15.07% | $231.38 | $196.51 |
| 2023 | +12.93% | $204.89 | $231.38 |
| 2022 | -27.38% | $282.14 | $204.89 |
| 2021 | +57.47% | $179.17 | $282.14 |
| 2020 | +15.96% | $154.51 | $179.17 |
| 2019 | +33.00% | $116.17 | $154.51 |
| 2018 | +18.66% | $97.90 | $116.17 |
| 2017 | +28.73% | $76.05 | $97.90 |
| 2016 | +10.76% | $68.66 | $76.05 |
| 2015 | +16.63% | $58.87 | $68.66 |
| 2014 | +27.04% | $46.34 | $58.87 |
Frequently Asked Questions: IQV
What sector is IQV in? ▼
IQV operates in the Healthcare sector, specifically in the Diagnostics & Research industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has IQV performed historically? ▼
Over 13 years of trading history, IQV has posted gains in 11 years (85% of the time). The best year was 2021 with a +57.5% return. Past performance does not guarantee future results.
How can I invest in IQV? ▼
You can invest in IQV through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold IQV.
Last updated: 11/1/2026